Bisphosphonates

IN150 > Pill - white capsule-shape

Pill with imprint IN150 > is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Watson Laboratories, Inc.

Ibandronate is used in the treatment of Prevention of Osteoporosis; Osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images

Ibandronate (oral/injection) (Ibandronate (oral/injection) [ eye-ban-dro-nate ])-IN150 >-150 mg (base)-White-Capsule-shape
Ibandronate (oral/injection) (Ibandronate (oral/injection) [ eye-ban-dro-nate ])-IN150 >-150 mg (base)-White-Capsule-shape
Ibandronate (oral/injection) (Ibandronate (oral/injection) [ eye-ban-dro-nate ])-IN150 >-150 mg (base)-White-Capsule-shape

Ibandronate (oral/injection)
Generic Name: ibandronate (oral/injection) [ eye-ban-dro-nate ]
Imprint: IN150 >
Strength: 150 mg (base)
Color: White
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Bisphosphonates
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Sorbitol, Microcrystalline cellulose, Silicon dioxide, Croscarmellose sodium, Sodium stearyl fumarate, Titanium dioxide, Magnesium silicate,
Latest News
Related Drugs